-The Hindu The entire spectrum of political leadership should take a pledge to transform the healthcare system of India in a decade As the countdown to the next general election begins, political parties are making multiple promises to pull in votes. All the party leaders are committing to transforming the lives of people. But health, ironically, does not feature high on their priority list, even though it is the central pillar of...

-The Telegraph New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies "escape routes" and promise little relief to consumers, a report released today has warned. The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside...

-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...

-The Times of India MUMBAI: Diabesity, a newly emerged term of medical science has taken more than one billion populations into its grip in past decade. Rising at an astounding level, diabesity has reached at an epidemic proportion. India is bracing for massive surge in diabesity with estimating number of sufferers in next 20 years at more than 100 million. Obesity is linked with diabetes, higher than normal body weight greatly increases...

-The Telegraph New Delhi: The US Chamber of Commerce has advised its government to ratchet up pressure on India over intellectual property rights and prevent it from producing cheap generic versions of medicines under patent protection. In a recommendation to the United States Trade Representative (USTR), the chamber requested it to label India as a Priority Foreign Country, a tag which is given to the worst offenders of patent rights. The only...